AzTrials
AzTrials

Cerebral PalsyAndreani1NCT02199015

Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy

A study testing Lateral spinal cord surgical implant of electrodes in people with Cerebral Palsy and Spasticity, run by Juan Carlos M. Andreani MD at 2 sites in 2 countries.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of our work is to investigate whether electrical Lateral Cord Stimulation (LCS) causes an inhibitory and modulatory action by indirect cerebellar activation, so releasing spasticity and the spastic syndrome in selected cases of patients with cerebral palsy Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Cerebral Palsy, Spasticity
What is being tested?
Lateral spinal cord surgical implant of electrodes
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesin 2 countries
Study dates
1 Jun 2027to 31 Dec 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Aged sixteen or older
  • Spastic Cerebral Palsy with stable condition
  • Motor disability unilateral or predominantly unilateral.
  • Troubles of speech clinically evident.
  • Normal or Slightly sub-normal I.Q
  • No psychiatric disorders.

Who cannot join

  • Severe cardiac or respiratory troubles
  • Fixed abnormal postures (except if previously corrected by orthopedic surgery)
  • Chronic recurrent bronchial or pulmonary infections
  • Chronic recurrent urinary infections
  • Severe osteoporosis on affected limbs
  • Chronic skin ulcerations.

Trial locations and contacts

2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

Juan Carlos Andreani, MD contact

5491150531392

jcmandreani@gmail.com

2 sites in 2 countries

Argentina1 site
  • Provincial Program of Neuromodulation

    La Plata, Buenos Aires, 1045

Other trials in Argentina

Germany1 site
  • Klinikummagdeburg

    Magdeburg, 399130

Other trials in Germany

About this study

Official title: Lateral Cord Electrical Stimulation Can Improve Spasticity in Chronic Spastic Cerebral Palsy

The aim of our work is to investigate whether electrical Lateral Cord Stimulation (LCS) causes an inhibitory and modulatory action by indirect cerebellar activation, so releasing spasticity and the spastic syndrome in selected cases of patients with cerebral palsy

Read the detailed description

PROJECT Lateral Cord Stimulation was thought by the author to be employed in patients with spastic cerebral palsy with the aim to improve tonus, motor function and speech.

Nevertheless, as it has been demonstrated as acting on the basic phenomena related with spasticity, it's to say the propagated spinal responses, its use could be extended to other forms of spastic disease, like spastic limbs post stroke, brain congenital malformations producing spasticity and motor disorders as the main signs, post anoxic encephalopathy, etc.

In this preliminary clinical trial, classed as phase 3, our sample must be very limited to assure stable conditions for statistical significance, hence our group is going to be circumscribed to certain conditions and pathology.

In the future, as long the method could spread its use, the extension on indications in other pathological conditions is advisable thus, its possibilities of marketing could be enlarged with its use in a broader spectrum of spastic patients.

Calculated risks are similar to those related with the ancient surgical technique called "Scoville"technique, currently employed time ago for cervical discectomy (6) Investigational plan The purpose of this clinical trial is to release spasticity and by this means improve the condition of patients with spastic cerebral palsy by extradural lateral cord electrical stimulation, by using currently employed electrodes and neurostimulators Those devices are already FDA approved and currently used for Dorsal Column Stimulation with the objective to treat chronic Pain and spasticity (Spasmodic Torticollis).

Being tested
Lateral spinal cord surgical implant of electrodes
Keywords
Dysarthria, Electrical Stimulation, Lateral Cord Stimulation, Spasticity, Treatment
Medical subject headings
Cerebral Palsy, Muscle Spasticity, Dysarthria

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lateral spinal cord surgical implant of electrodesDevice

    Also called Implant of Neurostimulators (electrical generators)

    The procedure is based on the classic approaches to posterior cervical region for herniated discs, actually not longer employed for that aim A unilateral hemilaminectomy will be performed at C3-C4 level, starting from 4th cervical spinous process.

    A multicontact electrode will be placed on the lateral surface of the spinal cord that will be subcutaneusly connected to an implanted pulse generator (IPG).

Study groups in NCT02199015
Study groupRoleWhat they receive
Spasticity, Cerebral PalsyExperimentalTo perform a Lateral spinal cord surgical implant of electrodes for electrical neuromodulation of a cohort of selectyed patients with refractory Spastic Cerebral Palsy To compare spasticity and speech trouble´s evolution on a cohort of treated patients, by evaluating their pre and post operative status into one year follow up.
Receives: Device: Lateral spinal cord surgical implant of electrodes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ashworth Scale

    The Ashworth scale has 5 points, they are: 1) no increase in muscle tone; 2) slight increase giving a catch when part is moved in flexion or extension; 3) more marked increase in tone but only after part is easily flexed; 4) considerable increase in tone; and 5) passive movement is difficult and affected part is rigid in flexion or extension

    Measured: Day 0 baseline evaluation. One post operative evaluation every 30 day during six months

Secondary outcomes (1)
  1. Barthel Index

    The Barthel Index consists of 10 items that measure a person's daily functioning specifically the activities of daily living and mobility of the patient. The items include feeding, moving from wheelchair,etc, and the whole evaluation is from 100 maximum what means total independence, to 0, absolute dependence

    Measured: Day 0 baseline evaluation. One post operative evaluation every 30 day during six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2014 (estimated)
  2. Study start1 Jun 2027 (estimated)
  3. Primary completion1 Apr 2029 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02199015
Sponsor's protocol ID
Andreani, JCM 1
Acronym
Andreani1
Status last verified
Apr 2026
First submitted
17 Jul 2014
Last updated
28 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Yes, we plan to share data as long as participants are recruited. Because there are not yet patients, we do not have data to share

Publications

  • Andreani JC, Guma C. New animal model to mimic spastic cerebral palsy: the brain-damaged pig preparation. Neuromodulation. 2008 Jul;11(3):196-201. doi: 10.1111/j.1525-1403.2008.00166.x.

    PubMed 22151096
  • Andreani JC, Guma C. Lateral cord stimulation decreases spastic electromyographic spreading: responses in a brain-damaged pig preparation. Neuromodulation. 2008 Jul;11(3):202-7. doi: 10.1111/j.1525-1403.2008.00167.x.

    PubMed 22151097

Questions about this trial

What is this clinical trial studying?

A study testing Lateral spinal cord surgical implant of electrodes in people with Cerebral Palsy and Spasticity, run by Juan Carlos M. Andreani MD at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Argentina, Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Juan Carlos Andreani, MD (5491150531392, jcmandreani@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ashworth Scale (time frame: Day 0 baseline evaluation. One post operative evaluation every 30 day during six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02199015, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in